|
|
Article: New Study Shows Chromium Picolinate and Biotin Combination Significantly Lowers Coronary Risk Factors in People with Type 2 Diabetes.
- Article from:
- PR Newswire
- Article date:
- May 6, 2004
|
Copyright informationCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Results from Diachrome(TM) Clinical Trial Presented at American Heart Association (AHA) ATVB Conference
(Nutrition 21, Inc. Nasdaq: NXXI) -- Results of a new double-blind, placebo-controlled, randomized clinical study show that daily nutritional supplementation with a combination of chromium picolinate and biotin (marketed as Diachrome(TM)) significantly improved coronary risk factors in people with type 2 diabetes. The clinical study, which evaluated 24 patients over 30 days, was presented today at the AHA's Annual Conference on Arteriosclerosis, Thrombosis & Vascular Biology (ATVB) in San Francisco.
The study found the following significant improvements in subjects ...